Respiratory devices market to hit $27.1 billion by 2030

The respiratory devices and equipment market is projected to grow from $13.62 billion in 2025 to $27.1 billion by 2030 as chronic lung disease, home care and connected devices reshape demand. Asia-Pacific led the market in 2025, while Western Europe ranked second.

Why it matters: - Respiratory devices and equipment are becoming more central to care for asthma, COPD, cystic fibrosis and acute respiratory distress syndrome. - Faster growth in home-based care, tele-respiratory services and connected monitoring could change how patients manage chronic breathing conditions. - The market expansion reflects rising pressure on health systems as respiratory disease prevalence keeps climbing worldwide.

What happened: - The respiratory devices and equipment market is projected to rise from $13.62 billion in 2025 to $15.34 billion in 2026. - The market is forecast to reach $27.1 billion by 2030. - The 2025-2026 growth implies a 12.7% CAGR. - The longer-term forecast implies a 15.3% CAGR through 2030. - Asia-Pacific was the largest regional market in 2025. - Western Europe ranked as the second-largest market in 2025. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - A free sample report is available. - The full market report is also available.

The details: - Respiratory devices and equipment include therapeutic and diagnostic tools designed to deliver medication, support oxygen levels and monitor lung function. - The devices are used in care for chronic respiratory illnesses and acute breathing problems. - Growth in the market has been driven by chronic respiratory illness, expansion of hospital respiratory care units, long-term oxygen therapy demand, ventilator improvements and broader use of non-invasive respiratory support. - The market's 2030 growth outlook is supported by home-based respiratory care, connected devices, tele-respiratory care, advanced ventilatory technologies and patient-centered management. - Key trends include integration of diagnostic and therapeutic systems, homecare device deployment, smart ventilation, oxygen therapy equipment, continuous monitoring and chronic disease management. - The World Health Organization reported in June 2025 that 81.7 million people worldwide live with chronic respiratory diseases and 6.8 million new cases are diagnosed each year. - Asia-Pacific's leadership is tied to rising respiratory disease prevalence, expanding healthcare infrastructure and greater awareness of respiratory health management. - Western Europe's large share reflects strong healthcare systems and advanced technology adoption.

Between the lines: - The market's growth suggests demand is shifting from hospital-only treatment toward more distributed care models. - Connected and smart devices are likely to matter more as health systems seek earlier intervention and continuous oversight. - Regional leadership points to where healthcare spending, infrastructure growth and disease burden are aligning fastest.

What's next: - The market is expected to keep expanding as respiratory care moves deeper into homes and digital care channels. - Investment is likely to continue in ventilatory technologies, monitoring tools and integrated respiratory systems. - The 2026 report edition adds market attractiveness scoring, TAM analysis, company scoring matrices, Excel forecasting dashboards, hotspot infographics and updated trend analysis. - The company provided contact details for expert inquiries and promoted its LinkedIn, Facebook and X accounts.